Connecting thyroid cancer patients with information and resources to manage their care. ITOG members include thyroid cancer patients who bring a unique perspective and commitment to our organization.

Our members include leading basic and translational investigators who strive to identify new drugs for thyroid cancer and perform clinical trials to bring targeted therapies to our patients.

Learn about the major types of thyroid cancer and how new cancer drugs are developed. Expand your understanding of the importance of participation in clinical trials.

Support our mission to catalyze a cure for thyroid cancer. Our work relies on the financial support from everyone who has been touched by these diseases.


REACT Feature


"The Board of Directors would like to thank you for supporting REACT, the inspiration of my dear daughter Michelle. Her passion and initiative to help others afflicted with medullary thyroid carcinoma (MTC) by creating REACT exemplifies her heart and selflessness. The REACT name and mission will be preserved with ITOG. You can continue to support the work of REACT through your existing mechanisms. You will also see greater involvement from our friends at ITOG." - Donna LeBeau

Until recently, there have been little to no options for those diagnosed with advanced thyroid cancer. Fortunately, in recent years, there has been great progress made in the area of clinical research and promising treatments are on the horizon. In order to keep the momentum going it is critical that the doctors and scientists have adequate funding to develop clinical trials and conduct research. Michelle was inspired to help make a difference and decided to start a non-profit foundation to do just that.

Michelle LeBeau

Michelle LeBeau, founder of REACT Thyroid Foundation
June 22, 1979 - June 8, 2015

Michelle was a visionary and an inspiration to everyone who knew her and beyond. We celebrate her courage, strength, and determination to leave behind a legacy.


The mission of the International Thyroid Oncology Group is to catalyze a cure for the most challenging thyroid cancers through the collaborative efforts of our unique multidisciplinary team of leading physicians, scientists, and advocates to design, coordinate, and prioritize state-of-the-art clinical trials and correlative science.

Our members have led paradigm changing clinical trials for thyroid cancer patients. These trials have already resulted in the FDA approval of two new drugs for medullary thyroid cancer, and innovative new approaches for treating differentiated thyroid cancer. We are doctors, scientists, and patients whose lives and careers are focused on identifying new therapies for thyroid cancer.

ITOG is building on the success of our members by forging collaborative efforts that can accelerate drug discovery and clinical trials. These efforts require your involvement. You can help us catalyze a cure by making a financial contribution to ITOG, a 501(c)(3) tax-exempt public charity; your contribution may be tax deductible.


International Thyroid Oncology Group
5166 Commercial Drive
Yorkville, New York 13495